Isorhynchophylline Attenuates MPP + -Induced Apoptosis Through Endoplasmic Reticulum Stress- and Mitochondria-Dependent Pathways in PC12 Cells: Involvement of Antioxidant Activity.

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
  • Author(s): Li XM;Li XM; Zhang XJ; Zhang XJ; Dong MX; Dong MX
  • Source:
    Neuromolecular medicine [Neuromolecular Med] 2017 Dec; Vol. 19 (4), pp. 480-492. Date of Electronic Publication: 2017 Aug 18.
  • Publication Type:
    Journal Article
  • Language:
    English
  • Additional Information
    • Source:
      Publisher: Humana Press Country of Publication: United States NLM ID: 101135365 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1559-1174 (Electronic) Linking ISSN: 15351084 NLM ISO Abbreviation: Neuromolecular Med Subsets: MEDLINE
    • Publication Information:
      Original Publication: Totowa, NJ : Humana Press, c2002-
    • Subject Terms:
    • Abstract:
      Endoplasmic reticulum stress (ERS) and mitochondrial dysfunctions are thought to be involved in the dopaminergic neuronal death in Parkinson's disease (PD). In this study, we found that isorhynchophylline (IRN) significantly attenuated 1-methyl-4-phenylpyridinium (MPP + )-induced apoptotic cell death and oxidative stress in PC12 cells. IRN markedly reduced MPP + -induced-ERS responses, indicative of inositol-requiring enzyme 1 (IRE1) phosphorylation and caspase-12 activation. Furthermore, IRN inhibits MPP + -triggered apoptosis signal-regulating kinase 1 (ASK1)/c-Jun N-terminal Kinase (JNK) signaling-mediated mitochondria-dependent apoptosis pathway. IRN-mediated attenuation of endoplasmic reticulum modulator caspase-12 activation was abolished by diphenyleneiodonium (DPI) or IRE-1α shRNA, but not by SP600125 or pifithrin-α in MPP + -treated PC12 cells. Inhibitions of MPP + -induced both cytochrome c release and caspase-9 activation by IRN were blocked by pre-treatment with DPI or pifithrin-α, but not by IRE-1α shRNA. IRN blocks the generation of reactive oxygen species upstream of both ASK1/JNK pathway and IRE1/caspase-12 pathway. Altogether, our in vitro findings suggest that IRN possesses potent neuroprotective activity and may be a potential candidate for the treatment of PD.
    • References:
      Exp Neurol. 2016 Jan;275 Pt 1:209-19. (PMID: 26571193)
      Cell Death Differ. 2006 Sep;13(9):1423-33. (PMID: 16676004)
      Apoptosis. 2016 Apr;21(4):432-42. (PMID: 26801321)
      Vet Q. 2014;34(3):120-31. (PMID: 25506807)
      Transl Neurodegener. 2014 Dec 10;3:27. (PMID: 25705376)
      Eur J Pharmacol. 2015 Oct 15;765:154-6. (PMID: 26297973)
      Toxicol Appl Pharmacol. 2012 Sep 1;263(2):148-62. (PMID: 22714038)
      J Heart Lung Transplant. 1999 May;18(5):478-87. (PMID: 10363693)
      Cell Biochem Biophys. 2016 Jun;74(2):213-20. (PMID: 26983927)
      Front Plant Sci. 2015 Sep 24;6:769. (PMID: 26442079)
      Yakugaku Zasshi. 2013;133(8):849-56. (PMID: 23903224)
      J Neurochem. 2011 Apr;117(1):112-20. (PMID: 21235576)
      Arch Toxicol. 2012 Jun;86(6):923-33. (PMID: 22622864)
      J Biol Chem. 2014 Oct 31;289(44):30567-77. (PMID: 25225294)
      J Neurosci. 2002 Dec 15;22(24):10690-8. (PMID: 12486162)
      J Pharm Pharmacol. 2008 Dec;60(12 ):1673-8. (PMID: 19000373)
      Parkinsonism Relat Disord. 2016 Oct;31:3-13. (PMID: 27461783)
      Cell Death Dis. 2015 Jul 30;6:e1822. (PMID: 26225772)
      Curr Opin Pharmacol. 2016 Feb;26:87-95. (PMID: 26571205)
      Biochim Biophys Acta. 2016 Aug;1863(8):1979-84. (PMID: 27157538)
      Mol Neurobiol. 2016 Jan;53(1):532-544. (PMID: 25482050)
      Free Radic Biol Med. 2016 Aug;97:454-465. (PMID: 27387771)
      Methods Mol Biol. 2009;572:203-18. (PMID: 20694694)
      Autophagy. 2012 Jan;8(1):98-108. (PMID: 22113202)
      Neuroscience. 2015 Jan 29;285:70-80. (PMID: 25446358)
      Mol Neurobiol. 2014 Feb;49(1):399-412. (PMID: 23934647)
      Neurotoxicol Teratol. 2014 Nov-Dec;46:1-9. (PMID: 25195717)
      Neurosci Lett. 2011 Jan 3;487(1):88-93. (PMID: 20934486)
      Neuromolecular Med. 2014 Jun;16(2):217-30. (PMID: 24522549)
      New Phytol. 2015 Aug;207(3):613-26. (PMID: 25784134)
      J Alzheimers Dis. 2014;39(2):331-46. (PMID: 24164737)
      Biochem Pharmacol. 2015 Jan 1;93(1):49-58. (PMID: 25449600)
      World J Gastroenterol. 2014 Dec 28;20(48):18189-98. (PMID: 25561786)
      Antioxid Redox Signal. 2002 Jun;4(3):405-14. (PMID: 12215208)
      Apoptosis. 2013 Jul;18(7):870-81. (PMID: 23546866)
      FEBS Lett. 2015 Aug 4;589(17):2241-7. (PMID: 26172506)
      CNS Neurosci Ther. 2014 Jul;20(7):591-602. (PMID: 24703487)
      J Neurosci Res. 2012 Sep;90(9):1850-60. (PMID: 22513717)
      J Ethnopharmacol. 2009 Nov 12;126(2):361-5. (PMID: 19703534)
      Anticancer Res. 2016 May;36(5):2281-9. (PMID: 27127134)
      Mov Disord. 2016 Sep;31(9):1356-65. (PMID: 27090868)
      Fitoterapia. 2014 Sep;97:156-63. (PMID: 24910000)
      Curr Protein Pept Sci. 2016;17 (2):169-82. (PMID: 26521955)
      Toxicol Sci. 2015 Sep;147(1):28-38. (PMID: 26048653)
      Development. 2015 Jun 1;142(11):1918-36. (PMID: 26015536)
      Neurochem Int. 2014 Oct;76:42-9. (PMID: 24984171)
      Ann N Y Acad Sci. 2005 Aug;1053:84-96. (PMID: 16179511)
    • Contributed Indexing:
      Keywords: Apoptosis; Endoplasmic reticulum stress; Isorhynchophylline; Mitochondria dysfunction; Parkinson’s disease
    • Accession Number:
      0 (Antioxidants)
      0 (Indole Alkaloids)
      0 (Neuroprotective Agents)
      0 (Neurotoxins)
      0 (Oxindoles)
      0 (Reactive Oxygen Species)
      46BQ79VJ8D (rhyncophylline)
      EC 2.7.- (Protein Kinases)
      R865A5OY8J (1-Methyl-4-phenylpyridinium)
      VTD58H1Z2X (Dopamine)
    • Publication Date:
      Date Created: 20170820 Date Completed: 20180718 Latest Revision: 20181202
    • Publication Date:
      20240628
    • Accession Number:
      10.1007/s12017-017-8462-x
    • Accession Number:
      28822073